Belimumab Impacting Transplant Eligibility

ClinicalTrials.gov ID: NCT02500251

Public ClinicalTrials.gov record NCT02500251. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 19, 2026, 2:00 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Belimumab-Based Plasma Cell Targeted Therapy to Impact Transplant Eligibility

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is a prospective, open label, phase I/II pilot study.

Study identification

NCT ID: NCT02500251
Recruitment status: Completed
Study type: Interventional
Phase: Phase 1, Phase 2
Lead sponsor: E. Steve Woodle; Other
Enrollment: 11 participants

Conditions and interventions

Conditions

Renal Transplant Rejection

Interventions

Drug

Eligibility (public fields only)

Age range: 18 Years to 65 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jun 2015 (Type not available)
Primary completion: Jun 2018 (Actual)
Completion: Aug 2018 (Actual)
Last update posted: Apr 22, 2019

2015 – 2018

United States locations

U.S. sites: 2
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
The Christ Hospital	Cincinnati	Ohio	45219	—
University of Cincinnati	Cincinnati	Ohio	45267	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02500251, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 22, 2019 · Synced Oct 19, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02500251 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →